AWM
GILD icon

Atticus Wealth Management’s Gilead Sciences GILD Stock Holding History

Atticus Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-84
Closed -$9.31K – 364
2025
Q2 		$9.31K Buy
+84
New +$8.94K ﹤0.01% 485
2023
Q1 		– Sell
-10
Closed -$858 – 561
2022
Q4 		$858 Sell
10
-86
-90% -$6.81K ﹤0.01% 497
2022
Q3 		$6K Hold
96
– – ﹤0.01% 419
2022
Q2 		$6K Buy
96
+50
+109% +$3.1K ﹤0.01% 450
2022
Q1 		$3K Buy
46
+36
+360% +$2.3K ﹤0.01% 494
2021
Q4 		$1K Sell
10
-11
-52% -$758 ﹤0.01% 422
2021
Q3 		$1K Sell
21
-3,100
-99% -$218K ﹤0.01% 391
2021
Q2 		$215K Buy
3,121
+13
+0.4% +$868 0.09% 107
2021
Q1 		$201K Sell
3,108
-70
-2% -$4.51K 0.1% 108
2020
Q4 		$185K Buy
3,178
+41
+1% +$2.47K 0.09% 103
2020
Q3 		$198K Buy
3,137
+135
+4% +$9.36K 0.12% 86
2020
Q2 		$231K Buy
3,002
+9
+0.3% +$690 0.15% 80
2020
Q1 		$224K Buy
2,993
+2,327
+349% +$161K 0.18% 71
2019
Q4 		$43K Buy
+666
New +$43.4K 0.03% 189

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Atticus Wealth Management's GILD Position: Q3 2025 in Review

Atticus Wealth Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 84 shares — an estimated $9.31K sold.

Atticus Wealth Management first reported a position in GILD in Q4 2019 and held it in 14 quarters. The position peaked at $231K in Q2 2020. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Atticus Wealth Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 84 Gilead Sciences shares in Q3 2025, an estimated $9.31K.
  • Atticus Wealth Management first reported a position in Gilead Sciences in Q4 2019 and held it in 14 quarters.
  • Atticus Wealth Management's Gilead Sciences position peaked at $231K in Q2 2020.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.